Literature DB >> 21249477

Bone marrow mesenchymal stem cells: biological properties and their role in hematopoiesis and hematopoietic stem cell transplantation.

Charalampos Pontikoglou1, Frédéric Deschaseaux, Luc Sensebé, Helen A Papadaki.   

Abstract

Mesenchymal stem cells (MSCs) are multipotent adult stem cells that are present in practically all tissues as a specialized population of mural cells/pericytes that lie on the abluminal side of blood vessels. Originally identified within the bone marrow (BM) stroma, not only do they provide microenvironmental support for hematopoietic stem cells (HSCs), but can also differentiate into various mesodermal lineages. MSCs can easily be isolated from the BM and subsequently expand in vitro and in addition they exhibit intriguing immunomodulatory properties, thereby emerging as attractive candidates for various therapeutic applications. This review addresses the concept of BM MSCs via a hematologist's point of view. In this context it discusses the stem cell properties that have been attributed to BM MSCs, as compared to those of the prototypic hematopoietic stem cell model and then gives a brief overview of the in vitro and vivo features of the former, emphasizing on their immunoregulatory properties and their hematopoiesis-supporting role. In addition, the qualitative and quantitative characteristics of BM MSCs within the context of a defective microenvironment, such as the one characterizing Myelodysplastic Syndromes are described and the potential involvement of these cells in the pathophysiology of the disease is discussed. Finally, emerging clinical applications of BM MSCs in the field of hematopoietic stem cell transplantation are reviewed and potential hazards from MSC use are outlined.

Entities:  

Mesh:

Year:  2011        PMID: 21249477     DOI: 10.1007/s12015-011-9228-8

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  205 in total

1.  Synovial fibroblasts and synovial macrophages from patients with rheumatoid arthritis and other inflammatory joint diseases show chromosomal aberrations.

Authors:  Raimund W Kinne; Elke Kunisch; Volkmar Beensen; Thomas Zimmermann; Frank Emmrich; Peter Petrow; Wolfgang Lungershausen; Gert Hein; Rudolf K Braun; Martin Foerster; Claus Kroegel; Rando Winter; Eckehard Liesaus; Renée A Fuhrmann; Andreas Roth; Uwe Claussen; Thomas Liehr
Journal:  Genes Chromosomes Cancer       Date:  2003-09       Impact factor: 5.006

Review 2.  Mesenchymal stem cells: a new strategy for immunosuppression?

Authors:  Antonio Uccelli; Vito Pistoia; Lorenzo Moretta
Journal:  Trends Immunol       Date:  2007-04-02       Impact factor: 16.687

3.  Factors required for bone marrow stromal fibroblast colony formation in vitro.

Authors:  S A Kuznetsov; A J Friedenstein; P G Robey
Journal:  Br J Haematol       Date:  1997-06       Impact factor: 6.998

4.  Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny.

Authors:  H Castro-Malaspina; R E Gay; G Resnick; N Kapoor; P Meyers; D Chiarieri; S McKenzie; H E Broxmeyer; M A Moore
Journal:  Blood       Date:  1980-08       Impact factor: 22.113

5.  Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase I-II clinical trial.

Authors:  M L Macmillan; B R Blazar; T E DeFor; J E Wagner
Journal:  Bone Marrow Transplant       Date:  2008-10-27       Impact factor: 5.483

6.  Homing of in vitro expanded Stro-1- or Stro-1+ human mesenchymal stem cells into the NOD/SCID mouse and their role in supporting human CD34 cell engraftment.

Authors:  Morad Bensidhoum; Alain Chapel; Sabine Francois; Christelle Demarquay; Christelle Mazurier; Loic Fouillard; Sandrine Bouchet; Jean Marc Bertho; Patrick Gourmelon; Jocelyne Aigueperse; Pierre Charbord; Norbert Claude Gorin; Dominique Thierry; Manuel Lopez
Journal:  Blood       Date:  2004-01-08       Impact factor: 22.113

7.  Favorable response to human adipose tissue-derived mesenchymal stem cells in steroid-refractory acute graft-versus-host disease.

Authors:  B Fang; Y Song; L Liao; Y Zhang; R C Zhao
Journal:  Transplant Proc       Date:  2007-12       Impact factor: 1.066

8.  Association of alkaline-phosphatase-positive reticulum cells in bone marrow with granulocytic precursors.

Authors:  H Westen; D F Bainton
Journal:  J Exp Med       Date:  1979-10-01       Impact factor: 14.307

9.  Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment.

Authors:  Olaia Naveiras; Valentina Nardi; Pamela L Wenzel; Peter V Hauschka; Frederic Fahey; George Q Daley
Journal:  Nature       Date:  2009-06-10       Impact factor: 49.962

10.  Mesenchymal stem cells.

Authors:  A I Caplan
Journal:  J Orthop Res       Date:  1991-09       Impact factor: 3.494

View more
  59 in total

1.  50 Hz electromagnetic field exposure promotes proliferation and cytokine production of bone marrow mesenchymal stem cells.

Authors:  Wenxia Fan; Fenghua Qian; Qinlong Ma; Pei Zhang; Tingting Chen; Chunhai Chen; Yong Zhang; Ping Deng; Zhou Zhou; Zhengping Yu
Journal:  Int J Clin Exp Med       Date:  2015-05-15

2.  Recent Patents Pertaining to Immune Modulation and Musculoskeletal Regeneration with Wharton's Jelly Cells.

Authors:  Limin Wang; Mark L Weiss; Michael S Detamore
Journal:  Recent Pat Regen Med       Date:  2013

3.  Chitosan/gelatin scaffolds support bone regeneration.

Authors:  Anthie Georgopoulou; Fotios Papadogiannis; Aristea Batsali; John Marakis; Kalliopi Alpantaki; Aristides G Eliopoulos; Charalampos Pontikoglou; Maria Chatzinikolaidou
Journal:  J Mater Sci Mater Med       Date:  2018-05-05       Impact factor: 3.896

4.  Comparable osteogenic capacity of mesenchymal stem or stromal cells derived from human amnion membrane and bone marrow.

Authors:  Mehran Ghasemzadeh; Ehteramolsadat Hosseini; Mohammadhossein Ahmadi; Maedeh Kamalizad; Naser Amirizadeh
Journal:  Cytotechnology       Date:  2018-01-05       Impact factor: 2.058

Review 5.  Cell Therapy for Ischemic Stroke: How to Turn a Promising Preclinical Research into a Successful Clinical Story.

Authors:  Gabrielle Mangin; Nathalie Kubis
Journal:  Stem Cell Rev Rep       Date:  2019-04       Impact factor: 5.739

6.  The Detrimental Effects of Kynurenine, a Tryptophan Metabolite, on Human Bone Metabolism.

Authors:  Beom-Jun Kim; Mark W Hamrick; Hyun Ju Yoo; Seung Hun Lee; Su Jung Kim; Jung-Min Koh; Carlos M Isales
Journal:  J Clin Endocrinol Metab       Date:  2019-06-01       Impact factor: 5.958

Review 7.  Mesenchymal stem cells: Potential role in corneal wound repair and transplantation.

Authors:  Fei Li; Shao-Zhen Zhao
Journal:  World J Stem Cells       Date:  2014-07-26       Impact factor: 5.326

8.  Transcriptional profiling reveals crosstalk between mesenchymal stem cells and endothelial cells promoting prevascularization by reciprocal mechanisms.

Authors:  Junxiang Li; Ying Ma; Ruifang Teng; Qian Guan; Jidong Lang; Jianhuo Fang; Haizhou Long; Geng Tian; Qiong Wu
Journal:  Stem Cells Dev       Date:  2014-11-25       Impact factor: 3.272

9.  Study of the quantitative, functional, cytogenetic, and immunoregulatory properties of bone marrow mesenchymal stem cells in patients with B-cell chronic lymphocytic leukemia.

Authors:  Charalampos Pontikoglou; Maria-Christina Kastrinaki; Mirjam Klaus; Christina Kalpadakis; Pavlos Katonis; Kalliopi Alpantaki; Gerassimos A Pangalis; Helen A Papadaki
Journal:  Stem Cells Dev       Date:  2013-02-01       Impact factor: 3.272

Review 10.  Is CD34 truly a negative marker for mesenchymal stromal cells?

Authors:  Ching-Shwun Lin; Hongxiu Ning; Guiting Lin; Tom F Lue
Journal:  Cytotherapy       Date:  2012-11       Impact factor: 5.414

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.